Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent Updates in Psychopharmacology for the Core and Associated Symptoms of Autism Spectrum Disorder
Authors
Keywords
-
Journal
Current Psychiatry Reports
Volume 23, Issue 12, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-13
DOI
10.1007/s11920-021-01292-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis
- (2021) Gian Loreto D’Alò et al. Health and Quality of Life Outcomes
- Cannabinoid treatment for autism: a proof-of-concept randomized trial
- (2021) Adi Aran et al. Molecular Autism
- Medication Use in the Management of Comorbidities Among Individuals With Autism Spectrum Disorder From a Large Nationwide Insurance Database
- (2021) Aliya G. Feroe et al. JAMA Pediatrics
- Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up
- (2020) Sylvie Bernaerts et al. Molecular Autism
- Folinic acid improves the score of Autism in the EFFET placebo-controlled randomized trial
- (2020) Emeline Renard et al. BIOCHIMIE
- Rationale, design, and methods of the autism centers of excellence (ACE) network study of oxytocin in autism to improve reciprocal social behaviors (SOARS-B)
- (2020) Marina Spanos et al. Contemporary Clinical Trials
- Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): A Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase Two, Superiority Trial
- (2020) Jan J. Sprengers et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy
- (2019) Lihi Bar-Lev Schleider et al. Scientific Reports
- Oral Cannabidiol Use in Children With Autism Spectrum Disorder to Treat Related Symptoms and Co-morbidities
- (2019) Dana Barchel et al. Frontiers in Pharmacology
- Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial
- (2019) Seyedeh-Mahsa Mahdavinasab et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism
- (2019) Karen J. Parker et al. Science Translational Medicine
- A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
- (2019) Federico Bolognani et al. Science Translational Medicine
- Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders
- (2019) Dinah S. Reddihough et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fluoxetine and Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorder
- (2019) Bryan H. King JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
- (2018) Hidenori Yamasue et al. MOLECULAR PSYCHIATRY
- A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures
- (2018) Laura C. Politte et al. NEUROPSYCHOPHARMACOLOGY
- Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial
- (2018) Jana A. Kruppa et al. NEUROPSYCHOPHARMACOLOGY
- Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension
- (2017) Michael G. Aman et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat
- (2017) Hala Harony-Nicolas et al. eLife
- A systematic review of pragmatic language interventions for children with autism spectrum disorder
- (2017) Lauren Parsons et al. PLoS One
- Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial
- (2016) R E Frye et al. MOLECULAR PSYCHIATRY
- Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder
- (2015) Lawrence Scahill et al. AMERICAN JOURNAL OF PSYCHIATRY
- Cerebral folate receptor autoantibodies in autism spectrum disorder
- (2012) R E Frye et al. MOLECULAR PSYCHIATRY
- A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders
- (2011) Eric Hollander et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Placebo-Controlled, Fixed-Dose Study of Aripiprazole in Children and Adolescents With Irritability Associated With Autistic Disorder
- (2009) Ronald N. Marcus et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
- (2009) R. Owen et al. PEDIATRICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started